2010
DOI: 10.1016/j.otohns.2009.12.028
|View full text |Cite
|
Sign up to set email alerts
|

Pulsating aerosols for drug delivery to the sinuses in healthy volunteers

Abstract: Our data support the hypothesis that topical drug delivery in relevant quantities to the nose and osteomeatal areas, including the paranasal sinuses, is possible using pulsating airflows. Furthermore, the frequency of drug applications may be reduced due to a delayed clearance and longer residence time.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
63
0
2

Year Published

2011
2011
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 61 publications
(67 citation statements)
references
References 14 publications
2
63
0
2
Order By: Relevance
“…For the prevention of the colonization of the donor lung with P. aeruginosa from the sinonasal segment, we instructed the patient to continuously inhale Colomycin 1 MIU twice daily into the lower airways and to administer Colomycin 1 MIU once daily into the upper airways (UAW). The utilized device is the Pari Sinus™ nebulizer which has been shown to deposit vibrating aerosols into the paranasal sinuses [2,3]. …”
Section: Case Reportsmentioning
confidence: 99%
“…For the prevention of the colonization of the donor lung with P. aeruginosa from the sinonasal segment, we instructed the patient to continuously inhale Colomycin 1 MIU twice daily into the lower airways and to administer Colomycin 1 MIU once daily into the upper airways (UAW). The utilized device is the Pari Sinus™ nebulizer which has been shown to deposit vibrating aerosols into the paranasal sinuses [2,3]. …”
Section: Case Reportsmentioning
confidence: 99%
“…An alternative to this could be Xenon-enhanced computed tomography (CT) or measurement of radionuclide deposition, both of which have been previously reported in the literature. 9,15 Last, given use of cadaver heads, no direct statements are possible about the potential role of the device in the clinical setting. Clinical trials in normal subjects and CRS patients (unoperated and operated) would be required, preferably with nebulized topical medications, to better evaluate the clinical relevance of the powered nebulizer.…”
Section: Discussionmentioning
confidence: 99%
“…[5][6][7][8][9] Preliminary studies with nebulized antibiotics have demonstrated improvement in both symptom and endoscopic parameters, with longer infection-free period. 10,11 Despite the frequent use of nebulized therapies for CRS, there is a relative paucity of studies assessing deposition of aerosol within the nose and paranasal sinuses.…”
Section: Rhinosinusitis (Crs)mentioning
confidence: 99%
“…15 Among the strategies employed to minimize exhalation losses, intermittent aerosol drug delivery has been used for numerous applications such as intermittent positive-pressure ventilation and drug delivery to the sinuses. [16][17][18][19] Using intermittent aerosol delivery, aerosol is delivered only during the inhalation portion of the breathing cycle to minimize exhalation losses. However, the effectiveness of this method has been controversial and has not been obvious in all applications.…”
Section: What This Paper Contributes To Our Knowledgementioning
confidence: 99%